Wave Life Sciences WVE US — Effective Income Tax Rate Reconciliation Tax Credits Research
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch.
The official record: Wave Life Sciences’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's us — effective income tax rate reconciliation tax credits research.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Wave Life Sciences's US — effective income tax rate reconciliation tax credits research?
- Wave Life Sciences (WVE) reported US — effective income tax rate reconciliation tax credits research of 0.6% in Q4 2025.
- What does US — effective income tax rate reconciliation tax credits research mean?
- This metric represents the percentage point reduction in the effective tax rate attributable to research and development tax credits. It demonstrates the efficacy of R&D tax incentives in lowering the company's overall tax burden. Investors monitor this to understand the impact of innovation-related tax policy on net profitability.